ArticleOncogene2023

A first-in-class fully modified version of miR-34a with outstanding stability, activity, and anti-tumor efficacy.

Ahmed M Abdelaal et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.